Normalization of up-regulated cardiac imidazoline I1-receptors and natriuretic peptides by chronic treatment with moxonidine in spontaneously hypertensive rats
被引:6
作者:
El-Ayoubi, R
论文数: 0引用数: 0
h-index: 0
机构:
Univ Montreal, Res Ctr, CHUM, Montreal, PQ, CanadaUniv Montreal, Res Ctr, CHUM, Montreal, PQ, Canada
El-Ayoubi, R
[1
]
Menaouar, A
论文数: 0引用数: 0
h-index: 0
机构:
Univ Montreal, Res Ctr, CHUM, Montreal, PQ, CanadaUniv Montreal, Res Ctr, CHUM, Montreal, PQ, Canada
Menaouar, A
[1
]
Gutkowska, J
论文数: 0引用数: 0
h-index: 0
机构:
Univ Montreal, Res Ctr, CHUM, Montreal, PQ, CanadaUniv Montreal, Res Ctr, CHUM, Montreal, PQ, Canada
Gutkowska, J
[1
]
Mukaddam-Daher, S
论文数: 0引用数: 0
h-index: 0
机构:
Univ Montreal, Res Ctr, CHUM, Montreal, PQ, CanadaUniv Montreal, Res Ctr, CHUM, Montreal, PQ, Canada
Mukaddam-Daher, S
[1
]
机构:
[1] Univ Montreal, Res Ctr, CHUM, Montreal, PQ, Canada
来源:
AGMATINE AND IMIDAZOLINES: THEIR NOVEL RECEPTORS AND ENZYMES
|
2003年
/
1009卷
The effect of treatment with moxonidine (120 mug/kg/h sc, 4 weeks) on cardiac I-1-receptors and natriuretic peptide synthesis was evaluated in spontaneously hypertensive rats (SHR). I-1-receptor protein (85 kD) was up-regulated in SHR atria, and normalized in right and left atria by moxonidine. Similarly, moxonidine normalized atrial and ventricular atrial natriuretic peptide messenger RNA (mRNA) and brain natriuretic peptide mRNA. This study shows that cardiac I-1-receptors are functional, being regulated by hypertension and by chronic exposure to agonist, and that cardiac natriuretic peptides may be regulated by I-1-receptor-mediated mechanisms.
机构:
Case Western Reserve Univ, Sch Med, Div Hypertens, Dept Nutr, Cleveland, OH 44106 USACase Western Reserve Univ, Sch Med, Div Hypertens, Dept Nutr, Cleveland, OH 44106 USA
机构:
Case Western Reserve Univ, Sch Med, Div Hypertens, Dept Nutr, Cleveland, OH 44106 USACase Western Reserve Univ, Sch Med, Div Hypertens, Dept Nutr, Cleveland, OH 44106 USA